Comprehensive Lipid Update Live Webinar Series 4 of 4

Date: August 31, 2020 @ 20.00-21.15 (Time Zone: GMT+3, Saudi Arabia, Bahrain)

Presented by: Dr. Alberto Zambon & Dr. Nasreen Alsayed

Moderated by: Dr. Fahad Alnouri

GOING LIVE IN
2020/08/31 20:00:00

Supported By

Prof. Alberto Zambon
Associate Professor of Medicine
University of Padova
Padova, Italy

View Bio

Professor Alberto Zambon received his MD from the University of Padua, Italy in 1988. He completed his post-doctoral Fellowship in Endocrinology at the University of Washington, the USA in 1991-1993 and again 1995-1997. He then obtained a Ph.D. in Gerontology from the University of Padua in 1998.

 

He is currently working as an Associate Professor of Medicine at the University of Padua where he is also the Director of the lipoprotein core laboratory of the Centre for Atherosclerosis Prevention and Treatment. He is simultaneously working as an Affiliate Assistant Professor in the Division of Endocrinology, Metabolism, and Nutrition, at the University of Washington.

 

He has authored / co-authored more than 80 peer-reviewed publications, 5 book chapters, and has delivered over 160 lectures as an invited speaker.

 

He is a recipient of several awards such as the American Federation For Aging Research (AFAR) in 1998, the Young Investigator Award in 2000, and the AZTECC International Award for Training and Education for Cardiovascular Clinicians in 2002.

 

Prof. Zambon is an active member of the Italian Society for the Study of Atherosclerosis (SISA), the European Atherosclerosis Society (EAS), and the International Atherosclerosis Society (IAS).

Dr. Nasreen Alsayed  
Consultant Endocrinologist and Lipidologist
Gulf Medical and Diabetes Center
Manama, Bahrain

View Bio

Dr. Al-Sayed graduated from Arabian Gulf University, college of Medicine in Bahrain. She is American Board Certified. She completed her Residency training in Internal medicine at Sinai-Grace Hospital, Wayne State University, Detroit, Michigan, USA and Fellowship training in Endocrinology and Diabetes at Cleveland Clinic Foundation, Ohio, USA. Dr. Al-Sayed is also American Board Certified in Clinical Lipidology and a fellow of American College of Physicians and fellow of American College of Endocrinologists. She has worked as assistant professor at Arabian Gulf University and is currently at Gulf Diabetes Specialist Center in Bahrain. Dr. Al-Sayed is a member of the National Lipid Association and other Diabetes and Endocrine Associations and has several research publications. She is a member of Board of Directors of the American Association of Clinical Endocrinologist, Gulf Chapter and a member of expert panel for Middle East Familial Hypercholesterolemia guidelines and FH Gulf registry. She is the National Lead investigator for FH in Bahrain.

Dr. Alsayed participated with expert panel and published first consensus recommendation for management of plasma lipid disorders for Middle East 2016. She has other several publications in the endocrine field.

Dr. Fahad Alnouri
Head, Cardiovascular Prevention Unit
Prince Sultan Cardiac Center
Riyadh, Saudi Arabia

  • 20:00-20:30

    Update on Lipid Guidelines: Case studies
    Presented by Nasreen Alsayed (Bahrain)

  • 20:30-21:00

    PCSK9 Inhibitors: A new era of lipid lowering therapy
    Presented by Alberto Zambon (Italy)

  • 21:00-21:15

    Q&A and Discussion
    Presented by Fahad Alnouri (KSA)

  • Endocrinologists
  • Pediatricians
  • Internist
  • Diabetologists

The accreditation for the Webinar is sought from the Dubai Health Authority (DHA).

CME will be provided up to 2 weeks post-webinar to your indicated email address. To obtain CME points, please make sure to complete the evaluation form after the presentation.

The webinar is accesible on PC and tablets. The use of a smartphone is also possible through your smartphone browser.

During questions and answers please submit your questions at the Q&A section.

A high-speed Internet connection is required (minimum 2 Mbps).